Roche Expands AI Factory with Nvidia
Analysis based on 9 articles · First reported Mar 16, 2026 · Last updated Mar 17, 2026
The expansion of Roche's AI factory, powered by Nvidia, is expected to significantly accelerate drug discovery and diagnostics, potentially leading to faster market entry for new treatments. This development could enhance Roche's competitive edge and drive innovation across the pharmaceutical and biotechnology sectors.
Roche announced a major expansion of its global AI infrastructure, establishing the pharmaceutical industry's largest announced hybrid-cloud AI factory. This expansion involves the addition of 2,176 NVIDIA Blackwell GPUs, bringing Roche's total GPU footprint to over 3,500 units across facilities in the United States and Europe. This strategic investment, building on a collaboration with Nvidia that began in 2023, aims to embed AI across the entire value chain, from discovery and development to manufacturing and commercialization. The AI factory will leverage Nvidia platforms like BioNeMo, Omniverse, and Parabricks to enhance R&D, optimize manufacturing processes through digital twins, and improve diagnostics and digital pathology. Wafaa Mamilli and Aviv Regev highlighted the importance of this computational power in accelerating the delivery of life-changing medicines and diagnostics, reinforcing Roche's vision of becoming an AI-accelerated healthcare organization.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard